Zhao, Y.; Yu, B.; Feng, W.; Xie, Y.; Shi, Y.; Cao, J.
Initial Denosumab Versus Sequential Bisphosphonate-to-Denosumab for Prevention of Skeletal-Related Events in Breast Cancer with Bone Metastases: A Retrospective, Single-Center Study. Cancers 2026, 18, 1222.
https://doi.org/10.3390/cancers18081222
AMA Style
Zhao Y, Yu B, Feng W, Xie Y, Shi Y, Cao J.
Initial Denosumab Versus Sequential Bisphosphonate-to-Denosumab for Prevention of Skeletal-Related Events in Breast Cancer with Bone Metastases: A Retrospective, Single-Center Study. Cancers. 2026; 18(8):1222.
https://doi.org/10.3390/cancers18081222
Chicago/Turabian Style
Zhao, Yannan, Bo Yu, Wanjing Feng, Yizhao Xie, Yuanyuan Shi, and Jun Cao.
2026. "Initial Denosumab Versus Sequential Bisphosphonate-to-Denosumab for Prevention of Skeletal-Related Events in Breast Cancer with Bone Metastases: A Retrospective, Single-Center Study" Cancers 18, no. 8: 1222.
https://doi.org/10.3390/cancers18081222
APA Style
Zhao, Y., Yu, B., Feng, W., Xie, Y., Shi, Y., & Cao, J.
(2026). Initial Denosumab Versus Sequential Bisphosphonate-to-Denosumab for Prevention of Skeletal-Related Events in Breast Cancer with Bone Metastases: A Retrospective, Single-Center Study. Cancers, 18(8), 1222.
https://doi.org/10.3390/cancers18081222
